Loading...
Market
Rite Aid stock to rise by more than 10% by end of July 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data from financial information services such as Yahoo Finance or Bloomberg
Story
Rite Aid Wins $200 Million Dispute Over Elixir Sale After Judge's Monday Ruling
Jun 24, 2024, 06:00 PM
Rite Aid has successfully defeated MedImpact Healthcare Systems in a $200 million dispute over the sale of its pharmacy benefit manager, Elixir. A judge ruled on Monday that MedImpact is not entitled to recoup the $200 million in extra costs, as it assumed Elixir's debts when it acquired the company. This ruling absolves Rite Aid of any responsibility for the additional costs tied to the recent acquisition.
View original story
Similar markets
Increase by > 5% • 25%
Increase by ≤ 5% • 25%
Decrease by ≤ 5% • 25%
Decrease by > 5% • 25%
Net Profit • 25%
Net Loss < $100 Million • 25%
Net Loss $100-$500 Million • 25%
Net Loss > $500 Million • 25%
